Journals / Pediatric Practice and Research / 2019 / Cilt: 7 - Sayı: 3

Quantitative Evaluation of MTHFR Enzyme in Neural Tube Defect Affected Children

Nöral tüp defekti etkilenen çocuklarda MTHFR enziminin kantitatif değerlendirilmesi

Pages
19–24
Publication Date
2019-12-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: It was found no role of fetal enzyme level in pathogenesis of NTD, in contrast, there was high MTHFR level in affected children, which might reflect a compensatory mechanism.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Neural tube defect (NTD) pathogenesis is still not understanding well and controversial.
📊
Key Findings & Data:Patients and methods: A cohort study was performed during 2017- 2018 in Al- Batool hospital.
💡
Conclusion & Impact:Conclusion: It was found no role of fetal enzyme level in pathogenesis of NTD, in contrast, there was high MTHFR level in affected children, which might reflect a compensatory mechanism.
🔬Design:Research Article
📍Scope:2017- 2018 Verileri
⚙️Variables:MTHFR · Neural tube defect · Congenital

Abstract

Background: Neural tube defect (NTD) pathogenesis is still not understanding well and controversial. Maternal Methylene Tetrahydrofolate Reductase (MTHFR) is an important enzyme controlling levels of methionine, homocysteine, and folic acid in the cycle of folate metabolism which has a considerable relationship with NTD development, while the role fetal MTHFR enzyme was not known till now. Objective: To evaluate the serum level of MTHFR in NTDs affected children to search if it is related to the defect pathogenesis. Patients and methods: A cohort study was performed during 2017- 2018 in Al- Batool hospital. A newly delivered NTD affected babies were included, serum level of MTHFR was measured by ELISA, results were compared to that of healthy neonates. SPSS version 22 was used for statistical analysis. Results: Forty six infants with NTD were included, spina bifida (n=39, 84.8%) and cranial NTD (7, 15.2%), females: males ratio was 1:1.35. MTHFR enzyme readings showed wide range in both healthy and NTD affected infants, generally, for cases they were insignificantly higher than that of control group (p value= 0.115); they were unrelated with the defect whether cranial or spinal, p value (0.264 ). Enzyme level significantly higher in NTD affected infants whom mothers aged more 35 yrs old (p value= 0.00) and insignificantly higher in babies whom mothers received folic acid than others. Conclusion: It was found no role of fetal enzyme level in pathogenesis of NTD, in contrast, there was high MTHFR level in affected children, which might reflect a compensatory mechanism.

🔖

Cite This Article

MAHMOOD, N. S. (2019). Quantitative Evaluation of MTHFR Enzyme in Neural Tube Defect Affected Children. Pediatric Practice and Research, Cilt: 7 - Sayı: 3, 19–24. https://ajindex.com/articles/795400

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Au K.S., Ashley-Koch A., Northrup H. Epidemiologic and genetic aspects of spina bifida and other neural tube defects. Dev. Disabil. Res. Rev. 2010;16:6–15. Lynch S.A. Non-multifactorial neural tube defects. Am. J. Med. Genet. C Semin. Med. Genet. 2005;135C:69–76. Blom H.J. Folic acid, methylation and neural tube closure in humans. Birth Defects Res. 2009;85:295–302.
  2. Blom H.J., Shaw G.M., den Heijer M., Finnell R.H. Neural tube defects and folate: Case far from closed. Nat. Rev. Neurosci. 2006;7:724–731.
  3. Blom H.J., Smulders Y. Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects. J. Inherit. Metab. Dis. 2011;34:75–81.
  4. De Marco P., Merello E., Cama A., Kibar Z., Capra V. Human neural tube defects: Genetic causes and prevention. Biofactors. 2011;37:261–268. Van der Put N.M., van Straaten H.W., Trijbels F.J., Blom H.J. Folate, homocysteine and neural tube defects: An overview. Exp. Biol. Med. 2001;226:243–270.
  5. Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol. 2000;151:862–877.
  6. Algasham A, Ismail H, Dewaidar M, Settin AA. Methylenetetrahydrofolate reductase and angiotensin-converting enzyme gene polymorphisms among saudi population from qassim region. Genet Test Mol Biomarkers2009;13:817-20.
  7. Scott JM, Weir DG, Molloy A, McPartlin J, Daly L, Kirke P. Folic acid metabolism and mechanisms of neural tube defects. Ciba Found Symp. 1994;181:180- 91. Apolline Imbard, Jean-François Benoist, Henk J. Blom. Neural tube defects, folic acid and methylation. Int J Environ Res Public Health. 2013 Sep; 10(9): 4352–4389.
  8. Van der Put NM, Blom HJ. Neural tube defects and a disturbed folate dependent homocysteine metabolism. Eur J ObstetGynecolReprod Biol. 2000;92:57–61. 13. Van der Put NM, van Straaten HW, Trijbels FJ, Blom HJ. Folate, homocysteine and neural tube defects: an overview. ExpBiol Med (Maywood) 2001;226:243–270.
  9. Kruger WD, Evans AA, Wang L, Malinow MR, Duell PB, Anderson PH, et al. Polymorphisms in the CBS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine lowering by folic acid. Mol Genet Metab. 2000;70:53–60.
  10. Peadar N Kirke, James L Mills, Anne M Molloy, Lawrence C Brody, Valerie B O'Leary, Leslie Daly, et al. Impact of the MTHFR C677T polymorphism on risk of neural tube defects: case-control study. BMJ. 2004 Jun 26; 328(7455): 1535–1536.
  11. Marini NJ, Hoffman